LASA / NSE / Biotechnology & Drugs
Lasa Supergenerics
1Y Price Trend
Key Information
Recommendations
Target High15.52
Target Low5.65
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk53
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Lasa Supergenerics promoter reports no new encumbrance in FY26 scanx.trade
Lasa Supergenerics Ltd Locks at Lower Circuit With 3.7% Loss — Sellers Queue, No Buyers in Sight Markets Mojo
Lasa Supergenerics Q4 FY26: Revenue Collapse Signals Critical Operational Crisis Markets Mojo
LASA Supergenerics discloses related party transactions for Q4FY26 scanx.trade
Lasa Supergenerics narrows net loss to ₹416.44 lakh in Q4FY26 scanx.trade
Lasa Supergenerics Posts Wider Net Loss of ₹34 Crore Amid Operations Suspension Whalesbook
Lasa Supergenerics Ltd is Rated Strong Sell Markets Mojo
Upper Circuit at Rs 8.38: Is Lasa Supergenerics Ltd’s 5% Surge Driven by Conviction or Thin Liquidity? Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026